- Conditions
- Gastroesophageal Reflux Disease
- Interventions
- Lansoprazole microgranules suspension, Placebo
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 1 Month to 11 Months
- Enrollment
- 162 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 9
- States / cities
- Tampa, Florida • Park Ridge, Illinois • Shreveport, Louisiana + 6 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–23
of 23
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Chronic Lung Disease
- Interventions
- Infant Pulmonary Function Tests
- Procedure
- Lead sponsor
- University of Tennessee
- Other
- Eligibility
- 1 Month to 24 Months
- Enrollment
- 26 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2011
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Bronchopulmonary Dysplasia, Gastroesophageal Reflux
- Interventions
- Transpyloric tube feeding, Gastric tube feeding
- Other
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 1 Month to 12 Months
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 4
- States / cities
- Palo Alto, California • Denver, Colorado • Kansas City, Missouri + 1 more
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Gastric Feeds, Jejunal Feeds
- Procedure
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 0 Hours to 1 Year
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Deglutition Disorders
- Interventions
- VFSS, FEES
- Other
- Lead sponsor
- Baylor Research Institute
- Other
- Eligibility
- 37 Weeks and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Feeding; Difficult, Newborn, Premature Infant Disease, Dysphagia of Newborn, Nurse's Role, Feeding Disorder of Infancy or Early Childhood, Trauma and Stressor Related Disorders, Deglutition Disorders in Infants, Malnutrition, Infant
- Interventions
- Not listed
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 33 Weeks to 50 Weeks
- Enrollment
- 76 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 4
- States / cities
- Chicago, Illinois • Downers Grove, Illinois • Oak Lawn, Illinois + 1 more
- Conditions
- Laryngomalacia, Acid Reflux, Stridor
- Interventions
- ranitidine or famotidine, Placebo
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- Up to 4 Months
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Gastroesophageal Reflux
- Interventions
- Rabeprazole sodium 5 mg, Rabeprazole sodium 10 mg, Placebo
- Drug
- Lead sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Industry
- Eligibility
- 1 Month to 11 Months
- Enrollment
- 344 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 43
- States / cities
- Birmingham, Alabama • Columbiana, Alabama • Dothan, Alabama + 40 more
- Conditions
- Gastroesophageal Reflux Disease (GERD)
- Interventions
- Open Label Run In Esomeprazole, Double Blind Esomeprazole, Double Blind Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 1 Month to 11 Months
- Enrollment
- 98 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 14
- States / cities
- Phoenix, Arizona • Atlanta, Georgia • Park Ridge, Illinois + 11 more
- Conditions
- Gastroesophageal Reflux
- Interventions
- pantoprazole
- Drug
- Lead sponsor
- University of Louisville
- Other
- Eligibility
- 28 Weeks to 11 Months
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Louisville, Kentucky
- Conditions
- Gastroesophageal Reflux
- Interventions
- pantoprazole, Placebo
- Drug
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 28 Days to 11 Months
- Enrollment
- 129 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 38
- States / cities
- Mobile, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 35 more
- Conditions
- Gastroesophageal Reflux Disease, Bronchopulmonary Dysplasia
- Interventions
- Fundoplication
- Procedure
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 24 Weeks to 1 Year
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Gastroesophageal Reflux Disease, GERD, Heartburn
- Interventions
- nizatidine (axid), placebo
- Drug
- Lead sponsor
- Braintree Laboratories
- Industry
- Eligibility
- 30 Days to 1 Year
- Enrollment
- 138 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 26
- States / cities
- Hot Springs, Arkansas • Jonesboro, Arkansas • Little Rock, Arkansas + 22 more
- Conditions
- Dysphagia, Airway Aspiration, Airway Penetration
- Interventions
- Combined testing (diagnostic VFSS + research HRM) + Parent Preferred Therapy
- Diagnostic Test
- Lead sponsor
- Sudarshan Jadcherla
- Other
- Eligibility
- 38 Weeks to 60 Weeks
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Gastroesophageal Reflux Disease
- Interventions
- Study Arm - acid suppression plus feeding bundle, Conventional arm - acid suppression only
- Other
- Lead sponsor
- Sudarshan Jadcherla
- Other
- Eligibility
- 34 Weeks to 60 Weeks
- Enrollment
- 76 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2020
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Dysphagia
- Interventions
- Cold Thin Liquid Barium
- Other
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- Up to 43 Weeks
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Mineola, New York
- Conditions
- Gastroesophageal Reflux
- Interventions
- Metaclopramide, Ranitidine, placebo
- Drug
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 1 Month to 6 Months
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2008
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Feeding Disorder Neonatal
- Interventions
- Esophageal stimulation with high resolution esophageal manometry and nutritive oral feeding therapy
- Procedure
- Lead sponsor
- Sudarshan Jadcherla
- Other
- Eligibility
- 1 Day to 8 Months
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Dysphagia of Newborn
- Interventions
- Standard room temperature (RTS) feeding of milk/formula, Cold temperature (CS, at 4-9°C) of milk/formula
- Other
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 35 Weeks and older
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Gastroesophageal Reflux
- Interventions
- pantoprazole sodium enteric-coated spheroid suspension
- Drug
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 1 Month to 11 Months
- Enrollment
- 67 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 16
- States / cities
- Little Rock, Arkansas • Loma Linda, California • San Diego, California + 13 more
- Conditions
- Gastroesophageal Reflux
- Interventions
- pantoprazole
- Drug
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 1 Day to 28 Days
- Enrollment
- 59 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 45
- States / cities
- Phoenix, Arizona • Loma Linda, California • Oakland, California + 42 more
- Conditions
- Gastroesophageal Reflux
- Interventions
- Rabeprazole sodium
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- Up to 44 Weeks
- Enrollment
- 69 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 10
- States / cities
- Orange, California • Washington D.C., District of Columbia • Augusta, Georgia + 7 more
- Conditions
- Gastroesophageal Reflux
- Interventions
- pantoprazole
- Drug
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 1 Day to 12 Months
- Enrollment
- 58 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 45
- States / cities
- Phoenix, Arizona • Loma Linda, California • Oakland, California + 42 more